Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.38 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13345043 | 0.95 | ALDH1A1 (0.38) | EGFRPOLBKDM4EALDH1A1 | |
| SCHEMBL17226387 | 0.82 | PTGS1 (0.37) | KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL13310458 | 0.80 | ALDH1A1 (0.43) | KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL13310455 | 0.79 | PTGS1 (0.36) | POLBKDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL29276557 | 0.76 | EGFR (0.54) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL13310457 | 0.75 | PTGS1 (0.41) | KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL17372277 | 0.75 | ALDH1A1 (0.40) | EGFRPOLBKDM4EALDH1A1CYP3A4 | |
| SCHEMBL16596086 | 0.73 | MAPT (0.41) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL12334352 | 0.73 | MAOB (0.37) | EGFRALDH1A1CYP3A4 | |
| SCHEMBL13310453 | 0.72 | KMT2A (0.58) | KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100132796-A1 | DYE COMPOUND FOR DYE-SENSITIZED SOLAR CELLS, DYE-SENSITIZED PHOTOELECTRIC CONVERTER AND DYE-SENSITIZED SOLAR CELLS | SAMSUNG ELECTRO-MECHANICS CO., LTD. | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100132796-A1 | DYE COMPOUND FOR DYE-SENSITIZED SOLAR CELLS, DYE-SENSITIZED PHOTOELECTRIC CONVERTER AND DYE-SENSITIZED SOLAR CELLS | CRY1, XPA, C1S | EGFR 3200/4885POLB 3016/4885KDM4E 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.